The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade ...

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

ACSCAM President Lisa Lacasse thanked Meghan McCain for “amplifying the critical importance of cancer research” and urged ...

Mia Love, the first Black Republican woman elected to the U.S. House, has brought renewed attention to an aggressive form of ...

Mia Love, the first Black Republican congresswoman, passes at 49 after battling glioblastoma, sparking discussions on the ...

The former lawmaker from Utah had undergone treatment for glioblastoma, a malignant brain tumor, and received immunotherapy ...

It's considered to be advanced by the time of diagnosis, meaning there is no way to eradicate all cancer cells. More than 13,000 Americans are diagnosed with glioblastoma each year, accounting for ...

Feb. 26, 2025 — Scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ...

The FDA has approved an investigational device exemption (IDE) application for the start of a pilot study evaluating the Alpha diffusing alpha-emitters radiation therapy (DaRT) technology in patients ...